Oncaspar - 54482-301-01 - (pegaspargase)

Alphabetical Index


Drug Information of Oncaspar

Product NDC: 54482-301
Proprietary Name: Oncaspar
Non Proprietary Name: pegaspargase
Active Ingredient(s): 750    [iU]/mL & nbsp;   pegaspargase
Administration Route(s): INTRAMUSCULAR; INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Oncaspar

Product NDC: 54482-301
Labeler Name: Sigma-Tau Pharmaceuticals, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA103411
Marketing Category: BLA
Start Marketing Date: 19940201

Package Information of Oncaspar

Package NDC: 54482-301-01
Package Description: 1 VIAL, SINGLE-USE in 1 CARTON (54482-301-01) > 5 mL in 1 VIAL, SINGLE-USE

NDC Information of Oncaspar

NDC Code 54482-301-01
Proprietary Name Oncaspar
Package Description 1 VIAL, SINGLE-USE in 1 CARTON (54482-301-01) > 5 mL in 1 VIAL, SINGLE-USE
Product NDC 54482-301
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name pegaspargase
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAMUSCULAR; INTRAVENOUS
Start Marketing Date 19940201
Marketing Category Name BLA
Labeler Name Sigma-Tau Pharmaceuticals, Inc.
Substance Name PEGASPARGASE
Strength Number 750
Strength Unit [iU]/mL
Pharmaceutical Classes Asparaginase [Chemical/Ingredient],Asparagine-specific Enzyme [EPC]

Complete Information of Oncaspar


General Information